The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.EBI
Imperial College
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.EBI
Imperial College
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.EBI
Imperial College
On the histone lysine methyltransferase activity of fungal metabolite chaetocin.EBI
Imperial College
Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.EBI
Imperial College
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies.EBI
Imperial College
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.EBI
Imperial College
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.EBI
Imperial College
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.EBI
Imperial College
Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.EBI
Imperial College
Resisting degradation by human elastase: commonality of design features shared by 'canonical' plant and bacterial macrocyclic protease inhibitor scaffolds.EBI
Imperial College
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration.EBI
Imperial College
Development of a new epidermal growth factor receptor positron emission tomography imaging agent based on the 3-cyanoquinoline core: synthesis and biological evaluation.EBI
Imperial College
Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold.EBI
Imperial College
Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide.EBI
Imperial College
Identification of anesthetic binding sites on human serum albumin using a novel etomidate photolabel.EBI
Imperial College
Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I.EBI
Imperial College
Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy.EBI
Imperial College
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.EBI
Imperial College
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).EBI
Imperial College
Design of symmetrical and nonsymmetrical EBI
Imperial College
Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs.EBI
Imperial College
Long chain base sphingosine kinase inhibitorsBDB
University of Virginia Patent Foundation